In April 2020 the Food and Drug Administration (FDA) ordered Zantac and generic ranitidine manufacturers to stop selling the popular heartburn medication due to potential Zantac cancer risks. According to the FDA and independent labs, Zantac and other ranitidine-containing medications may be contaminated with NDMA, a chemical known to cause cancer. Have you taken Zantac or generic ranitidine? Are you at risk of developing potential Zantac-related cancer? FEBRUARY 2023 UPDATE: Due to recent developments in the litigation, our firm is no longer accepting Zantac claims. Please stay tuned to our website for the latest information and updates.
Potential Zantac Cancer: What is the Danger?
In late 2019, an independent lab warned the FDA that it had discovered NDMA contamination in ranitidine, including brand name Zantac. NDMA is a volatile organic compound that is found in trace amounts in water and food — but at elevated levels it may cause cancer.
At the time, the FDA began an investigation into Zantac as major pharmacies like Walgreens, CVS and RiteAid pulled Zantac and ranitidine from shelves. Certain manufacturers issued voluntary recalls.
In April 2020, however, the FDA issued an urgent warning about Zantac cancer risk.
Specifically, the FDA stated that it had detected elevated levels of potentially cancer-causing NDMA in Zantac and generic ranitidine, and that contrary to previous reports, elevated NDMA levels were associated with all types of storage conditions.
Potential Zantac cancers possibly associated with NDMA contamination include:
- Stomach cancer
- Kidney cancer
- Bladder cancer
- Intestinal cancer
- Colorectal cancer
- Testicular cancer
- Thyroid cancer
- Breast cancer
- Throat/nasal cancer
- Brain cancer
- Liver cancer
- Lung cancer
- Esophageal cancer
- Pancreatic cancer
- Prostate cancer
- Ovarian cancer
- Uterine cancer
- Non-Hodgkins lymphoma
- Multiple myeloma
- Leukemia
If You Are Taking Zantac…
If you or a loved one take prescription Zantac or a generic equivalent, or over-the-counter (OTC) Zantac or generic ranitidine, be aware that the FDA has warned that these taking these medicines may cause cancer.
Those with Zantac prescriptions are encouraged to talk with their doctor immediately about the risks and potential Zantac alternatives.
Those taking Zantac or ranitidine medication over-the-counter are encouraged to stop taking the medicine immediately and consider Zantac alternatives. There are many alternative heartburn medications that have not been associated with NDMA contamination.
>>For more information about potential Zantac alternatives, please check out our guide to Zantac alternatives.
Have you taken Zantac and been diagnosed with cancer?
FEBRUARY 2023 UPDATE: Due to recent developments in the litigation, our firm is no longer accepting Zantac claims. Please stay tuned to our website for the latest information and updates. Those who have taken brand-name Zantac and developed cancer potentially due to NDMA contamination deserve justice and may be entitled to significant financial compensation.You may qualify for a Zantac lawsuit if you meet the following criteria:
- Used brand-name Zantac only
- Suffered from at least one of the following cancers:
- Bladder cancer
- Liver cancer
- Stomach cancer
- Esophageal cancer
- Pancreatic cancer
- Must have used brand-name Zantac after October 1984
- Must have used brand-name Zantac for a minimum of one year
- Must have used brand-name Zantac once per week for a minimum of six months
- Must have been diagnosed with a qualifying cancer within 20 years of last dose
- Must not have been a smoker in the past 20 years if diagnosed with lung cancer
- Must be 64 years of age or younger at the time of diagnosis if diagnosed with prostate cancer
Certain other criteria may apply. For a FREE, no-obligation consultation with an experienced Zantac lawsuit attorney, please call 1-800-525-7111.
FEBRUARY 2023 UPDATE: Due to recent developments in the litigation, our firm is no longer accepting Zantac claims. Please stay tuned to our website for the latest information and updates. PLEASE NOTE: At this time, the federal MDL has limited the Zantac claims we can accept to bladder, esophageal, stomach, liver, and pancreatic cancers only. We understand that other cancers may be linked, but we are unfortunately unable to assist with these claims at this time due to evidence and recent court rulings. For a FREE, no-obligation consultation with an experienced Zantac cancer lawsuit attorney, please call 1-800-525-7111.
There are absolutely no upfront costs and no attorney fees unless we win your case and you receive financial compensation.
Please call 1-800-525-7111 to speak with a Zantac cancer lawyer today.
IMPORTANT: A federal judge recently ruled against lawsuits concerning generic Zantac. At this point, we can only accept cases concerning use of brand-name Zantac OR “mixed” use of brand-name Zantac and generic equivalents.
The drug injury attorneys at Riddle & Brantley have been holding potentially negligent pharmaceutical companies accountable since 1985. We are committed to justice for those hurt due to the negligence of others, and we would love to help you however we can.
Riddle & Brantley is led by attorney Gene Riddle. Gene is a member of Million Dollar Advocates Forum and Multi-Million Dollar Advocates Forum, recognizing attorneys who have secured the most significant settlements and judgments (see disclaimers below). He is also recognized by Super Lawyers and has an AV Preeminent rating from Martindale-Hubbell. In 2014, attorney Riddle was awarded the Litigator Award (see disclaimer below).
“Those who have been diagnosed with cancer potentially as a result of taking Zantac deserve justice.”-Gene Riddle, managing partner and attorney, Riddle & Brantley For a FREE case review with a Zantac cancer lawyer regarding you or a loved one’s eligibility for a potential Zantac lawsuit, please call 1-800-525-7111. You may be entitled to compensation and you deserve justice. We believe Justice Counts for those injured due to potential negligence by drug manufacturers and we would love to help however we can.
***Disclaimer: No settlement agreement has been reached in any litigation regarding ranitidine (ZANTAC®), including in the Multidistrict Litigation in the United States District Court for the Southern District of Florida (case no. 20-MD-2924). *** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case. *** Disclaimer: An attorney must meet certain requirements to join these organizations or receive these awards. For more information on Membership Criteria for Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, The National Trial Lawyers Top 100, AV Preeminent by Martindale-Hubbell and the Litigator Award, please visit our Membership Criteria page. These awards and memberships should not be construed as a promise or guarantee of a similar result. Each case is different and must be evaluated separately.